Kinesio Taping on Trapezius Trigger Points After Integrated Neuromuscular Inhibition Technique (INIT)

September 11, 2019 updated by: Riphah International University

Effects of Kinesio Taping on Upper Trapezius Trigger Points After Integrated Neuromuscular Inhibition Technique (INIT)

The aim of this research is to see the effects of kinesio taping after integrated neuromuscular inhibition technique on pain, disability, pain-pressure threshold and muscle length in patients with upper trapezius trigger points. There will be two groups experimental and control. One study group will receive kinesiotaping after integrated neuromuscular inhibition technique and the other group will only receive integrated neuromuscular inhibition technique.

Study Overview

Detailed Description

This study is Randomized controlled trail done at physiotherapy department of Railway General Hospital Rawalpindi. The sample size of 26 individuals calculated using open epi tool. Sampling technique applied was convenience sampling. Randomization in groups by sealed envelope method. The subjects were divided into two groups with 13 patients each. Both groups were treated with Integrated neuromuscular inhibition technique (Muscle energy Technique, sustain pressure, Strain counter-strain) while Kinesio tape was applied after INIT in only experimental group. Study duration was of 6 months. Individuals having age between 20-40 years, upper trapezius active or latent trigger points, limited side bending were included in this study. Tools used in the study were neck disability index (NDI), algometry, numeric pain rating scale (NPRS) and muscle length (side bending through inclinometer). Assessments were taken on 1st day pre and post intervention and on 4th day.

Study Type

Interventional

Enrollment (Actual)

26

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Federal, Pakistan
      • Islamabad,, Federal, Pakistan, Pakistan, 44000
        • Riphah International University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

20 years to 50 years (ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Upper Trapezius Active or latent trigger points
  • Limited range of motion (cervical Side Bending)

Exclusion Criteria:

  • Radiculopathies
  • Malignancy
  • Infection
  • Trauma

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: TREATMENT
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: SINGLE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
EXPERIMENTAL: Kinesiotape Group and INIT
Kinesiotaping and Integrated Neuromuscular Inhibition Technique (KT + INIT )
Total of 4 sessions on upper trapezius trigger points on alternate days.
Sustain Pressure. Strain Counter-strain (for 90 sec) Passive Isometric Relaxation (PIR) (6-10 sec hold, 4 reps)
ACTIVE_COMPARATOR: INIT Group
Integrated Neuromuscular Inhibition Technique (INIT)
Sustain Pressure. Strain Counter-strain (for 90 sec) Passive Isometric Relaxation (PIR) (6-10 sec hold, 4 reps)

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Neck disability index
Time Frame: 4th Day
Changes from the baseline, The NDI is a modification of the neck disability index and it was developed by Vernon and Mior. It was designed to measure the neck pain and disability over time. It consists of 10 items, five parts sections. At the end, score is calculated by dividing the obtained score by total 50 multiplied by 100.
4th Day
Pain-Pressure threshold (PPT)
Time Frame: 4th day
Changes from the baseline, Pain-pressure threshold was measured with the help of an algometer.
4th day
NPRS
Time Frame: 4th Day
Changes from the baseline, Numeric Pain rating scale is a scale for pain intensity starting from 0-10. Where 0 indicates no pain and 10 indicate severe pain.
4th Day

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Muscle length measure
Time Frame: 4th Day
Changes from the baseline, Muscle length of upper trapezius was measured with the help of Inclinometer
4th Day

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

February 1, 2019

Primary Completion (ACTUAL)

June 20, 2019

Study Completion (ACTUAL)

June 30, 2019

Study Registration Dates

First Submitted

September 4, 2019

First Submitted That Met QC Criteria

September 11, 2019

First Posted (ACTUAL)

September 13, 2019

Study Record Updates

Last Update Posted (ACTUAL)

September 13, 2019

Last Update Submitted That Met QC Criteria

September 11, 2019

Last Verified

September 1, 2019

More Information

Terms related to this study

Other Study ID Numbers

  • RiphahIU Nowal Kamran

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Trigger Points

Clinical Trials on Kinesiotaping

3
Subscribe